| HOME >> MEDICINE >> TECHNOLOGY |
Rochester Medical CorporationPress Release - F12 Third QuarterSummary Statements Of Operations (unaudited)(unaudited)Three months endedNine months endedJune 30,June 30,2012201120122011Sales$ 15,252,218$ 14,280,558$ 44,356,495$ 38,079,563Cost of sales7,801,8967,280,93022,507,96419,316,610Gross profit7,450,3226,999,62821,848,53118,762,953Gross profit %48.8%49.0%49.3%49.3%Costs and expenses:Marketing and selling4,435,9124,991,62613,159,52413,649,370Research and development
358,552222,974982,710752,500General and administrative
1,942,9412,276,4956,179,7786,626,269Total operating expenses6,737,4057,491,09520,322,01221,028,139Income (loss) from operations712,917(491,467)1,526,519(2,265,186)Other income (expense)Interest income8,91749,60128,117154,148Interest expense-(70,239)(89,545)(225,094)Other income13,335(22,603)42,392(51,750)Net income (loss) before income taxes
735,169(534,708)1,507,483(2,387,882)Income tax expense (benefit)239,245(240,744)484,392(665,439)Net income (loss)$
495,924$
(293,964)$
,023,091$
(1,722,443)Earnings (loss) per common share - Basic
$
.04$
(0.02)$
.09$
(0.14)Earnings (loss) per common share - Diluted
$
.04$
(0.02)$
.08$
(0.14)Weighted Average Shares:12,008,42012,316,87812,036,12412,222,146BasicWeighted Average Shares:Diluted12,373,34012,316,87812,340,04512,222,146
Rochester Medical CorporationPress Release - F12 Third Quarter Condensed Balance Sheets(unaudited)June 30,September 30,20122011AssetsCurrent AssetsCash and equivalents$
'/>"/>
| SOURCE Rochester Medical Corporation Copyright©2012 PR Newswire. All rights reserved |